Effect of Nebivolol on Oxidative Stress and Endothelial Progenitor Cells in Subjects With Hypertension.

Trial Profile

Effect of Nebivolol on Oxidative Stress and Endothelial Progenitor Cells in Subjects With Hypertension.

Completed
Phase of Trial: Phase IV

Latest Information Update: 31 Dec 2014

At a glance

  • Drugs Nebivolol (Primary) ; Metoprolol succinate
  • Indications Hypertension
  • Focus Pharmacodynamics
  • Most Recent Events

    • 15 May 2014 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
    • 06 Nov 2012 Planned end date changed from 1 Dec 2011 to 1 Dec 2013 as reported by ClinicalTrials.gov.
    • 09 Jan 2010 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top